glp-1 usage by country Ozempic Statistics: Weight Loss Medication Data North America Glucagon-Like Peptide-1 (GLP-1)
Description
Should I increase dose if weight loss slows
Is it safe to start anti-obesity medications early in treatment
Overall tolerability of the treatment was good, with the most common side effect being nausea, particularly during treatment initiation or dose adjustments, while diarrhea was reported by 5% of patients, which was dose-dependent and easily managed
Moreover, patients on tirzepatide should also be monitored for adverse effects, especially if an increased dose was prescribed
